NCT00612027View on ClinicalTrials.gov

Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions

CompletedOBSERVATIONAL
Enrollment

29,586

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2006

Conditions
Gastrointestinal Diseases
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY